文献速递血液净化与透析慢性肾脏病

尿毒症毒素分类及其在肾衰竭中的作用

Classification of Uremic Toxins and Their Role in Kidney Failure.
PubMed 文献 · Clin J Am Soc Nephrol · 2021-07-07

本文基于共识会议,提出结合尿毒症潴留溶质的理化特性、透析清除模式及其与临床症状和结局的关联,更新尿毒症毒素的定义与分类方案,主要聚焦血液透析清除,并建议识别代表性生物标志物以推动个体化透析处方。

要点

  • 共识推荐按理化特性和透析清除模式对尿毒症毒素进行整体分类。
  • 识别各类毒素的代表性生物标志物有助于个体化透析处方。
  • 未来研究应聚焦尿毒症溶质理解与CKD患者结局改善。

核心结论

  • 共识会议提出基于理化特性、透析清除模式及临床关联的尿毒症毒素更新定义与分类方案。

研究设计与样本

  • 共识会议制定推荐,主要聚焦血液透析对尿毒症潴留溶质的清除。

主要发现

  • 识别不同类别尿毒症溶质的代表性生物标志物及其与临床症状和结局的相关性,可能促进个体化靶向透析处方。

临床怎么用

  • 可依据毒素分类和代表性生物标志物,个体化制定透析处方以改善生活质量、发病率和死亡率。

局限性

  • 原文未报告共识会议的具体方法学细节及推荐条款的量化标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Advances in our understanding of uremic retention solutes, and improvements in hemodialysis membranes and other techniques designed to remove uremic retention solutes, offer opportunities to readdress the definition and classification of uremic toxins. A consensus conference was held to develop recommendations for an updated definition and classification scheme on the basis of a holistic approach that incorporates physicochemical characteristics and dialytic removal patterns of uremic retention solutes and their linkage to clinical symptoms and outcomes. The major focus is on the removal of uremic retention solutes by hemodialysis. The identification of representative biomarkers for different classes of uremic retention solutes and their correlation to clinical symptoms and outcomes may facilitate personalized and targeted dialysis prescriptions to improve quality of life, morbidity, and mortality. Recommendations for areas of future research were also formulated, aimed at improving understanding of uremic solutes and improving outcomes in patients with CKD.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Rosner MH, Reis T, Husain-Syed F, et al. Classification of Uremic Toxins and Their Role in Kidney Failure. Clin J Am Soc Nephrol. 2021. PMID: 34233920. doi:10.2215/CJN.02660221

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。